US Broker Ratings

Stryker Corporation (SYK) Stock Analysis: Exploring a 37% Upside Potential with Strong Buy Ratings

Stryker Corporation (NYSE: SYK) stands out as a compelling player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $109.33 billion, the company..

argenx SE (ARGX) Stock Analysis: Tapping Into a 32% Upside in the Booming Biotech Sector

argenx SE (NASDAQ: ARGX), a Netherlands-based biopharmaceutical company, is creating significant buzz in the healthcare sector, particularly within the biotechnology industry. With a robust market capitalization of $48.88 billion, argenx..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 25% Potential Upside Amid Robust Revenue Growth

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, continues to capture investor attention with a robust market cap of $356.49 billion. This biopharmaceutical giant is renowned for..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential Amid Strong Analyst Ratings

Amgen Inc. (AMGN), a titan in the healthcare sector, stands out in the drug manufacturing industry with its robust pipeline of human therapeutics. With a market capitalization of $179.12 billion,..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unlocking 12.71% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a pivotal player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has captured investor attention with a potential upside of..

UnitedHealth Group (UNH) Stock Analysis: Navigating the Healthcare Giant’s Growth and Dividend Potential

UnitedHealth Group Incorporated (NYSE: UNH), a leading player in the healthcare plans industry, continues to hold a firm grip on the market with a substantial market capitalization of $345.08 billion...

Medtronic plc (MDT) Stock Analysis: A 41.83% Potential Upside with Strong Buy Ratings

Medtronic plc (NYSE: MDT), a global leader in the medical devices industry, is attracting significant investor interest with an impressive potential upside of 41.83%. Headquartered in Galway, Ireland, Medtronic’s market..

Insulet Corporation (PODD) Stock Analysis: A 62% Potential Upside Beckons Investors

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector, particularly in the medical devices industry, with its innovative insulin delivery systems. The company’s flagship products, such as the Omnipod..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 27.84% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, renowned for its focus on transformative medicines targeting serious diseases. With a market capitalization of $109.09..

IDEXX Laboratories (IDXX) Stock Analysis: Unveiling a 26.61% Potential Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling case for investors with its robust market presence..

Novartis AG (NVS) Stock Analysis: Evaluating a Potential 5.37% Upside in a Healthcare Giant

Novartis AG (NVS), a titan in the global healthcare sector, stands as a formidable presence in the pharmaceutical industry with a market capitalization of $278.64 billion. Headquartered in Basel, Switzerland,..

Eli Lilly and Company (LLY) Stock Analysis: A Strong Buy with 27% Upside Potential

Investors are keeping a close eye on Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector with a market capitalization of $845.77 billion. Known for its robust..

Thermo Fisher Scientific Inc (TMO): An Investor Outlook with Strong Buy Ratings and Robust Revenue Growth

Thermo Fisher Scientific Inc (NYSE: TMO), a dominant player in the healthcare sector, continues to captivate investors with its robust performance in the diagnostics and research industry. Headquartered in Waltham,..

Abivax SA (ABVX) Stock Analysis: Unpacking the 24.51% Potential Upside Amidst Strong Buy Ratings

Abivax SA (ABVX), a trailblazer in the biotechnology sector, has captured investor attention with its promising potential upside of 24.51%. Headquartered in Paris, France, this clinical-stage biotechnology company is making..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a Potential 149.49% Upside in Biotech

Maze Therapeutics, Inc. (MAZE), a clinical-stage biopharmaceutical company headquartered in South San Francisco, has garnered significant attention in the biotechnology sector for its innovative approach to treating kidney and metabolic..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring Growth Potential Amidst a $1.47 Billion Market Cap

Fortrea Holdings Inc. (NASDAQ: FTRE), a relatively new player in the biotechnology sector, is garnering attention from investors with its promising growth potential and strategic focus. Headquartered in Durham, North..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Evaluating a Promising 77.94% Upside Potential

Myriad Genetics, Inc. (NASDAQ: MYGN) is a notable player in the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Salt Lake City, Utah, the company specializes in..

Prothena Corporation plc (PRTA) Stock Analysis: Biotechnology Innovator with a 99.62% Potential Upside

Prothena Corporation plc (NASDAQ: PRTA) has emerged as a significant player within the biotechnology sector, captivating investor attention with its promising pipeline and a substantial potential upside of 99.62%. This..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Investors Eye 107% Upside Potential

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) presents a compelling opportunity for investors interested in the biotechnology sector, particularly those focused on companies addressing rare diseases. With a market capitalization of $650.27..

Standard BioTools Inc. (LAB) Stock Analysis: A 55% Potential Upside Beckons Investors

Standard BioTools Inc. (NASDAQ: LAB), a player in the medical devices sector, offers a compelling opportunity for investors with an eye for high-potential biotech stocks. Headquartered in Boston, Massachusetts, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds